Key facts
- Notable investors include Tech Incubator Program for Startup, IBK Changgong, Center for Creative Economy and Innovation, BiiG WAVE, Small and Medium Business Administration Branch of the Korean Government.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for J&J Tech
- ·The full record, as it builds
Funding rounds
No funding rounds for J&J Tech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About J&J Tech
Developer of pharmaceutical management software designed to improve pharmacists' efficiency through artificial intelligence technology. The company's application offers features including automated dispensing inspection, medicine counting, drug information search, inventory and return management, and mobile ordering, enabling pharmacists to improve efficiency, reduce errors, and enhance patient care.
- Sector
- Healthcare
- HQ
- Incheon, South Korea
- Founded
- 2021
- Employees
- 12
- Website
- yakmanager.com/
- Ownership
- Privately Held (backing)
J&J Tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in J&J Tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on J&J Tech in its N-PORT filings yet. We sweep new filings monthly.